Abstract
Allostery is considered one of the most direct and efficient ways to regulate biological macromolecule functions. Allostery is increasingly receiving attention in the field of drug discovery because of the unique advantages of allosteric modulators such as high selectivity and low toxicity. Because of technical breakthroughs in the allosteric studies, the understanding of the characteristics of allosteric entities such as allosteric proteins and their allosteric sites and modulators has made great strides. These features play a critical role in both the evolution of the allosteric concept and the prediction of allosteric interactions. In this chapter, we highlight the fundamental characteristics of allosteric proteins, allosteric sites, and allosteric modulators. Importantly, the applications of such principles in real cases are depicted in detail. Collectively, these characteristics are beneficial in aiding allosteric drug design and allosteric mechanism research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Araújo-Bazán L, Ruiz-Avila LB, Andreu D, Huecas S, Andreu JM (2016) Cytological profile of antibacterial FtsZ inhibitors and synthetic peptide MciZ. Front Microbiol 7:1558
Artola M, Ruíz-Avila LB, Ramírez-Aportela E, Martínez RF, Araujo-Bazán L, Vázquez-Villa H, Martín-Fontecha M, Oliva MA, Martín-Galiano AJ, Chacón P (2017) The structural assembly switch of cell division protein FtsZ probed with fluorescent allosteric inhibitors. Chem Sci 8:1525–1534
Babel H, Bischofs IB (2016) Molecular and cellular factors control signal transduction via switchable allosteric modulator proteins (SAMPs). BMC Syst Biol 10:35
Badireddy S, Yunfeng G, Ritchie M, Akamine P, Wu J, Kim CW, Taylor SS, Qingsong L, Swaminathan K, Anand GS (2010) Cyclic AMP analog blocks kinase activation by stabilizing inactive conformation: conformational selection highlights a new concept in allosteric inhibitor design. Mol Cell Proteomics 10. https://doi.org/10.1074/mcp.M110.004390
Bai X, Yan C, Yang G, Lu P, Ma D, Sun L, Zhou R, Scheres SHW, Shi Y (2015) An atomic structure of human γ-secretase. Nature 525:212–217
Banerjee S, Bartesaghi A, Merk A, Rao P, Bulfer SL, Yan Y, Green N, Mroczkowski B, Neitz RJ, Wipf P (2016) 2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition. Science 351:871–875
Berezin C, Glaser F, Rosenberg J, Paz I, Pupko T, Fariselli P, Casadio R, Ben-Tal N (2004) ConSeq: the identification of functionally and structurally important residues in protein sequences. Bioinformatics 20:1322–1324
Bessa LM, Launay H, Dujardin M, Cantrelle F-X, Lippens G, Landrieu I, Schneider R, Hanoulle X (2017) NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B. J Biol Chem 292:18024–18043
Betzi S, Alam R, Martin M, Lubbers DJ, Han H, Jakkaraj SR, Georg GI, Schönbrunn E (2011) Discovery of a potential allosteric ligand binding site in CDK2. ACS Chem Biol 6:492–501
Bian Z-M, Elner SG, Khanna H, Murga-Zamalloa CA, Patil S, Elner VM (2011) Expression and functional roles of caspase-5 in inflammatory responses of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 52:8646–8656
Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411:355–365
Bock A, Schrage R, Mohr K (2018) Allosteric modulators targeting CNS muscarinic receptors. Neuropharmacology 136:427–437
Bonomi M, Pellarin R, Vendruscolo M (2018) Simultaneous determination of protein structure and dynamics using cryo-electron microscopy. Biophys J 114:1604–1613
Boulton S, Melacini G (2016) Advances in NMR methods to map allosteric sites: from models to translation. Chem Rev 116:6267–6304
Bowman GR, Bolin ER, Hart KM, Maguire BC, Marqusee S (2015) Discovery of multiple hidden allosteric sites by combining Markov state models and experiments. Proc Natl Acad Sci U S A 112:2734–2739
Brignole EJ, Tsai K-L, Chittuluru J, Li H, Aye Y, Penczek PA, Stubbe J, Drennan CL, Asturias F (2018) 3.3-Å resolution cryo-EM structure of human ribonucleotide reductase with substrate and allosteric regulators bound. Elife 7:e31502
Bryant C, Fitzgerald KA (2009) Molecular mechanisms involved in inflammasome activation. Trends Cell Biol 19:455–464
Buzko O, Shokat KM (2002) A kinase sequence database: sequence alignments and family assignment. Bioinformatics 18:1274–1275
Campitelli P, Guo J, Zhou H-X, Ozkan SB (2018) Hinge-shift mechanism modulates allosteric regulations in human pin1. J Phys Chem B 122:5623–5629
Capdevila DA, Braymer JJ, Edmonds KA, Wu H, Giedroc DP (2017) Entropy redistribution controls allostery in a metalloregulatory protein. Proc Natl Acad Sci U S A 114:4424–4429
Celniker G, Nimrod G, Ashkenazy H, Glaser F, Martz E, Mayrose I, Pupko T, Ben-Tal N (2013) ConSurf: using evolutionary data to raise testable hypotheses about protein function. Isr J Chem 53:199–206
Chandramohan A, Krishnamurthy S, Larsson A, Nordlund P, Jansson A, Anand GS (2016) Predicting allosteric effects from orthosteric binding in Hsp90-ligand interactions: implications for fragment-based drug design. PLoS Comput Biol 12:e1004840
Changeux J-P (2010) Allosteric receptors: from electric organ to cognition. Annu Rev Pharmacol Toxicol 50:1–38
Changeux J-P (2012) Allostery and the Monod-Wyman-Changeux model after 50 years. Annu Rev Biophys 41:103–133
Changeux J-P (2013) 50 years of allosteric interactions: the twists and turns of the models. Nat Rev Mol cell Biol 14:819–829
Chen I (2013) Allostery through DNA. Nat Struct & Mol Biol 20:410
Chen H, Marsiglia WM, Cho M-K, Huang Z, Deng J, Blais SP, Gai W, Bhattacharya S, Neubert TA, Traaseth NJ (2017) Elucidation of a four-site allosteric network in fibroblast growth factor receptor tyrosine kinases. Elife 6:e21137
Cheng RKY, Fiez-Vandal C, Schlenker O, Edman K, Aggeler B, Brown DG, Brown GA, Cooke RM, Dumelin CE, Doré AS, Geschwindner S, Grebner C, Hermansson N-O, Jazayeri A, Johansson P, Leong L, Prihandoko R, Rappas M, Soutter H, Snijder A, Sundström L, Tehan B, Thornton P, Troast D, Wiggin G, Zhukov A, Marshall FH, Dekker N (2017) Structural insight into allosteric modulation of protease-activated receptor 2. Nature 545:112–115
Chodera JD, Noé F (2014) Markov state models of biomolecular conformational dynamics. Curr Opin Struct Biol 25:135–144
Christopoulos A (2002) Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 1:198–210
Coleman JA, Green EM, Gouaux E (2016) X-ray structures and mechanism of the human serotonin transporter. Nature 532:334–339
Collier G, Ortiz V (2013) Emerging computational approaches for the study of protein allostery. Arch Biochem Biophys 538:6–15
Cong X, Liu Y, Liu W, Liang X, Laganowsky A (2017) Allosteric modulation of protein-protein interactions by individual lipid binding events. Nat Commun 8:2203
Congreve M, Oswald C, Marshall FH (2017) Applying structure-based drug design approaches to allosteric modulators of GPCRs. Trends Pharmacol Sci 38:837–847
Conn PJ, Christopoulos A, Lindsley CW (2009a) Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 8:41–54
Conn PJ, Jones CK, Lindsley CW (2009b) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol Sci 30:148–155
Conn PJ, Lindsley CW, Meiler J, Niswender CM (2014) Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders. Nat Rev Drug Discov 13:692–708
Csermely P, Korcsmáros T, Kiss HJM, London G, Nussinov R (2013) Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther 138:333–408
Csizmok V, Orlicky S, Cheng J, Song J, Bah A, Delgoshaie N, Lin H, Mittag T, Sicheri F, Chan HS, Tyers M, Forman-Kay JD (2017) An allosteric conduit facilitates dynamic multisite substrate recognition by the SCFCdc4 ubiquitin ligase. Nat Commun 8:13943
Das D, Krantz BA (2016) Peptide- and proton-driven allosteric clamps catalyze anthrax toxin translocation across membranes. Proc Natl Acad Sci U S A 113:9611–9616
De Cesco S, Kurian J, Dufresne C, Mittermaier AK, Moitessier N (2017) Covalent inhibitors design and discovery. Eur J Med Chem 138:96–114
Demerdash ONA, Daily MD, Mitchell JC (2009) Structure-based predictive models for allosteric hot spots. PLoS Comput Biol 5:e1000531
Di Russo NV, Martí MA, Roitberg AE (2014) Underlying thermodynamics of ph-dependent allostery. J Phys Chem B 118:12818–12826. https://doi.org/10.1021/jp507971v
Digby GJ, Noetzel MJ, Bubser M, Utley TJ, Walker AG, Byun NE, Lebois EP, Xiang Z, Sheffler DJ, Cho HP (2012) Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models. J Neurosci 32:8532–8544
Dokholyan NV (2016) Controlling Allosteric Networks in Proteins. Chem Rev 116:6463–6487
Doré AS, Okrasa K, Patel JC, Serrano-Vega M, Bennett K, Cooke RM, Errey JC, Jazayeri A, Khan S, Tehan B (2014) Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain. Nature 511:557–561
Dror RO, Pan AC, Arlow DH, Borhani DW, Maragakis P, Shan Y, Xu H, Shaw DE (2011) Pathway and mechanism of drug binding to G-protein-coupled receptors. Proc Natl Acad Sci U S A 108:13118–13123
Dror RO, Green HF, Valant C, Borhani DW, Valcourt JR, Pan AC, Arlow DH, Canals M, Lane JR, Rahmani R, Baell JB, Sexton PM, Christopoulos A, Shaw DE (2013) Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs. Nature 503:295–299
Eddy MT, Lee M-Y, Gao Z-G, White KL, Didenko T, Horst R, Audet M, Stanczak P, McClary KM, Han GW, Jacobson KA, Stevens RC, Wüthrich K (2018) Allosteric coupling of drug binding and intracellular signaling in the A2A adenosine receptor. Cell 172:68–80.e12. https://doi.org/10.1016/j.cell.2017.12.004
Elsen NL, Lu J, Parthasarathy G, Reid JC, Sharma S, Soisson SM, Lumb KJ (2012) Mechanism of action of the cell-division inhibitor PC190723: modulation of FtsZ assembly cooperativity. J Am Chem Soc 134:12342–12345
Engers DW, Lindsley CW (2013) Allosteric modulation of Class C GPCRs: a novel approach for the treatment of CNS disorders. Drug Discov Today Technol 10:e269–e276
Fang Z, Grütter C, Rauh D (2012) Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural features. ACS Chem Biol 8:58–70
Fenton AW (2008) Allostery: an illustrated definition for the ‘second secret of life.’. Trends Biochem Sci 33:420–425
Foda ZH, Seeliger MA (2014) An allosteric add-on. Nat Chem Biol 10:796–797
Foda ZH, Shan Y, Kim ET, Shaw DE, Seeliger MA (2015) A dynamically coupled allosteric network underlies binding cooperativity in Src kinase. Nat Commun 6:5939
Gafurov B, Chen Y-D, Chalovich JM (2004) Ca(2+) and ionic strength dependencies of S1-ADP binding to actin-tropomyosin-troponin: regulatory implications. Biophys J 87:1825–1835. https://doi.org/10.1529/biophysj.104.043364
Ganesan A, Coote ML, Barakat K (2017) Molecular dynamics-driven drug discovery: leaping forward with confidence. Drug Discov Today 22:249–269
Gangoso E, Talaverón R, Jaraíz-Rodríguez M, Domínguez-Prieto M, Ezan P, Koulakoff A, Medina JM, Giaume C, Tabernero A (2017) A c-Src inhibitor peptide based on connexin43 exerts neuroprotective effects through the inhibition of glial hemichannel activity. Front Mol Neurosci 10:418
Gao Z-G, Jacobson KA (2013) Allosteric modulation and functional selectivity of G protein-coupled receptors. Drug Discov Today Technol 10:e237–e243
Gao J, Wells JA (2012) Identification of specific tethered inhibitors for caspase-5. Chem Biol Drug Des 79:209–215
Gao Y, Shen L, Honzatko RB (2014) Central cavity of fructose-1,6-bisphosphatase and the evolution of AMP/fructose 2,6-bisphosphate synergism in eukaryotic organisms. J Biol Chem 289:8450–8461
Gardino AK, Villali J, Kivenson A, Lei M, Liu CF, Steindel P, Eisenmesser EZ, Labeikovsky W, Wolf-Watz M, Clarkson MW (2009) Transient non-native hydrogen bonds promote activation of a signaling protein. Cell 139:1109–1118
Gasper PM, Fuglestad B, Komives EA, Markwick PRL, McCammon JA (2012) Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities. Proc Natl Acad Sci U S A 109:21216–21222
Gentry PR, Sexton PM, Christopoulos A (2015) Novel allosteric modulators of G protein-coupled receptors. J Biol Chem 290:19478–19488
Gibbons DL, Pricl S, Kantarjian H, Cortes J, Quintás-Cardama A (2012) The rise and fall of gatekeeper mutations? the BCR-ABL1 T315I paradigm. Cancer 118:293–299
Gill-Thind JK, Dhankher P, D’Oyley JM, Sheppard TD, Millar NS (2014) Structurally similar allosteric modulators of α7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects. J Biol Chem 290:3552–3562
Goldenberg O, Erez E, Nimrod G, Ben-Tal N (2008) The ConSurf-DB: pre-calculated evolutionary conservation profiles of protein structures. Nucleic Acids Res 37:D323–D327
Goodey NM, Benkovic SJ (2008) Allosteric regulation and catalysis emerge via a common route. Nat Chem Biol 4:474–482
Greener JG, Sternberg MJE (2018) Structure-based prediction of protein allostery. Curr Opin Struct Biol 50:1–8
Grimm SS, Isacoff EY (2016) Allosteric substrate switching in a voltage sensing lipid phosphatase. Nat Chem Biol 12:261–267
Grover AK (2013) Use of allosteric targets in the discovery of safer drugs. Med Princ Pract 22:418–426
Guarnera E, Berezovsky IN (2016) Allosteric sites: remote control in regulation of protein activity. Curr Opin Struct Biol 37:1–8
Gunasekaran K, Ma B, Nussinov R (2004) Is allostery an intrinsic property of all dynamic proteins? Proteins Struct Funct Bioinforma 57:433–443
Halabi N, Rivoire O, Leibler S, Ranganathan R (2009) Protein sectors: evolutionary units of three-dimensional structure. Cell 138:774–786
Handley LD, Fuglestad B, Stearns K, Tonelli M, Fenwick RB, Markwick PRL, Komives EA (2017) NMR reveals a dynamic allosteric pathway in thrombin. Sci Rep 7:39575
Hardy JA, Wells JA (2004) Searching for new allosteric sites in enzymes. Curr Opin Struct Biol 14:706–715
Hertig S, Latorraca NR, Dror RO (2016) Revealing atomic-level mechanisms of protein allostery with molecular dynamics simulations. PLoS Comput Biol 12:e1004746
Hines JK, Fromm HJ, Honzatko RB (2007) Structures of activated fructose-1, 6-bisphosphatase from Escherichia coli: coordinate regulation of bacterial metabolism and the conservation of the r-state. J Biol Chem 282:11696–11704
Hocker HJ, Cho K-J, Chen C-YK, Rambahal N, Sagineedu SR, Shaari K, Stanslas J, Hancock JF, Gorfe AA (2013) Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function. Proc Natl Acad Sci U S A 110:10201–10206
Hu Y, Li S, Liu F, Geng L, Shu X, Zhang J (2015) Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays. Bioorg Med Chem Lett 25:4069–4073
Huang Z, Zhu L, Cao Y, Wu G, Liu X, Chen Y, Wang Q, Shi T, Zhao Y, Wang Y, Li W, Li Y, Chen H, Chen G, Zhang J (2011) ASD: a comprehensive database of allosteric proteins and modulators. Nucleic Acids Res 39:D663–D669
Huang M, Lu S, Shi T, Zhao Y, Chen Y, Li X, Liu X, Huang Z, Zhang J (2013a) Conformational transition pathway in the activation process of allosteric glucokinase. PLoS One 8:e55857
Huang W, Lu S, Huang Z, Liu X, Mou L, Luo Y, Zhao Y, Liu Y, Chen Z, Hou T (2013b) Allosite: a method for predicting allosteric sites. Bioinformatics 29:2357–2359
Huang Z, Mou L, Shen Q, Lu S, Li C, Liu X, Wang G, Li S, Geng L, Liu Y (2014) ASD v2. 0: updated content and novel features focusing on allosteric regulation. Nucleic Acids Res 42:D510–D516
Huang M, Song K, Liu X, Lu S, Shen Q, Wang R, Gao J, Hong Y, Li Q, Ni D, Xu J, Chen G, Zhang J (2018) AlloFinder: a strategy for allosteric modulator discovery and allosterome analyses. Nucleic Acids Res 46:W451–W458
Isaacs JS, Xu W, Neckers L (2003) Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3:213–217
Isherwood SN, Robbins TW, Dalley JW, Pekcec A (2018) Bidirectional variation in glutamate efflux in the medial prefrontal cortex induced by selective positive and negative allosteric mGluR5 modulators. J Neurochem 145:111–124
Jacobson KA (2015) New paradigms in GPCR drug discovery. Biochem Pharmacol 98:541–555
Jaffe EK (2005) Morpheeins–a new structural paradigm for allosteric regulation. Trends Biochem Sci 30:490–497
Jaffe EK, Lawrence SH (2012) The morpheein model of allostery: evaluating proteins as potential morpheeins. In: Allostery. Springer, pp 217–231. https://doi.org/10.1007/978-1-61779-334-9
Johnson LN, Lewis RJ (2001) Structural basis for control by phosphorylation. Chem Rev 101:2209–2242
Kar G, Keskin O, Gursoy A, Nussinov R (2010) Allostery and population shift in drug discovery. Curr Opin Pharmacol 10:715–722
Kenakin T (2007) Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 28:407–415
Kenakin TP (2017) Chapter 5 – allosteric drug effects. In: Kenakin TPBT-P in DD and D, 2nd edn. Academic Press, Amsterdam, pp 101–129
Kim S, Broströmer E, Xing D, Jin J, Chong S, Ge H, Wang S, Gu C, Yang L, Gao YQ, Su X, Sun Y, Xie XS (2013) Probing Allostery Through DNA. Science (80- ) 339:816–819
Kim JG, Kim TW, Kim J, Ihee H (2015) Protein structural dynamics revealed by time-resolved X-ray solution scattering. Acc Chem Res 48:2200–2208
Kityk R, Vogel M, Schlecht R, Bukau B, Mayer MP (2015) Pathways of allosteric regulation in Hsp70 chaperones. Nat Commun 6:8308
Knight ZA, Lin H, Shokat KM (2010) Targeting the cancer kinome through polypharmacology. Nat Rev Cancer 10:130–137
Kobilka BK, Deupi X (2007) Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 28:397–406
Korczynska M, Clark MJ, Valant C, Xu J, Von Moo E, Albold S, Weiss DR, Torosyan H, Huang W, Kruse AC, Lyda BR, May LT, Baltos J-A, Sexton PM, Kobilka BK, Christopoulos A, Shoichet BK, Sunahara RK (2018) Structure-based discovery of selective positive allosteric modulators of antagonists for the M2 muscarinic acetylcholine receptor. Proc Natl Acad Sci U S A 115:E2419–E2428. https://doi.org/10.1073/pnas.1718037115
Kornev AP, Taylor SS (2015) Dynamics-driven allostery in protein kinases. Trends Biochem Sci 40:628–647
Koshland DE Jr, Némethy G, Filmer D (1966) Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry 5:365–385
Kruger FA, Overington JP (2012) Global analysis of small molecule binding to related protein targets. PLoS Comput Biol 8:e1002333
Kruse AC, Ring AM, Manglik A, Hu J, Hu K, Eitel K, Hübner H, Pardon E, Valant C, Sexton PM (2013) Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature 504:101–106
Lazareno S, Doležal V, Popham A, Birdsall NJM (2004) Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. Mol Pharmacol 65:257–266
Lee J, Natarajan M, Nashine VC, Socolich M, Vo T, Russ WP, Benkovic SJ, Ranganathan R (2008) Surface sites for engineering allosteric control in proteins. Science (80- ) 322:438–442
Lee Y, Choi S, Hyeon C (2014) Mapping the intramolecular signal transduction of G-protein coupled receptors. Proteins Struct Funct Bioinforma 82:727–743
Levy ED, Teichmann SA (2013) Structural, evolutionary, and assembly principles of protein oligomerization. Prog Mol Biol Transl Sci 117:25–51
Li X, Chen Y, Lu S, Huang Z, Liu X, Wang Q, Shi T, Zhang J (2013) Toward an understanding of the sequence and structural basis of allosteric proteins. J Mol Graph Model 40:30–39
Liu X, Ahn S, Kahsai AW, Meng K-C, Latorraca NR, Pani B, Venkatakrishnan AJ, Masoudi A, Weis WI, Dror RO, Chen X, Lefkowitz RJ, Kobilka BK (2017) Mechanism of intracellular allosteric β2AR antagonist revealed by X-ray crystal structure. Nature 548:480–484
Lockless SW, Ranganathan R (1999) Evolutionarily conserved pathways of energetic connectivity in protein families. Science (80- ) 286:295–299
Louet M, Seifert C, Hensen U, Gräter F (2015) Dynamic allostery of the catabolite activator protein revealed by interatomic forces. PLoS Comput Biol 11:e1004358
Lu S, Zhang J (2017) Designed covalent allosteric modulators: an emerging paradigm in drug discovery. Drug Discov Today 22:447–453. https://doi.org/10.1016/j.drudis.2016.11.013
Lu S, Zhang J (2018) Small molecule allosteric modulators of G-protein-coupled receptors: drug–target interactions. J Med Chem. https://doi.org/10.1021/acs.jmedchem.7b01844
Lu S, Huang W, Zhang J (2014a) Recent computational advances in the identification of allosteric sites in proteins. Drug Discov Today 19:1595–1600
Lu S, Li S, Zhang J (2014b) Harnessing allostery: a novel approach to drug discovery. Med Res Rev 34:1242–1285
Lu S, Jang H, Muratcioglu S, Gursoy A, Keskin O, Nussinov R, Zhang J (2016) Ras conformational ensembles, allostery, and signaling. Chem Rev 116:6607–6665
Lu S, Ji M, Ni D, Zhang J (2017) Discovery of hidden allosteric sites as novel targets for allosteric drug design. Drug Discov Today 23:359–365
Lü W, Du J, Goehring A, Gouaux E (2017) Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation. Science (80- ) 355:eaal3729
Lutkenhaus J, Pichoff S, Du S (2012) Bacterial cytokinesis: from Z ring to divisome. Cytoskeleton 69:778–790
Macpherson JA, Anastasiou D (2017) Allosteric regulation of metabolism in cancer: endogenous mechanisms and considerations for drug design. Curr Opin Biotechnol 48:102–110
Modesti M (2011) Fluorescent labeling of proteins. In: Single molecule analysis. Springer, New York, pp 101–120
Monod J, Wyman J, Changeux J-P (1978) On the nature of allosteric transitions: a plausible model. In: Selected papers in molecular biology by Jacques Monod. Elsevier, Amsterdam, pp 593–623
Motlagh HN, Wrabl JO, Li J, Hilser VJ (2014) The ensemble nature of allostery. Nature 508:331–339
Muchmore DB (2000) Raloxifene: a selective estrogen receptor modulator (SERM) with multiple target system effects. Oncologist 5:388–392
Newcombe J, Chatzidaki A, Sheppard TD, Topf M, Millar NS (2018) Diversity of nicotinic acetylcholine receptor positive allosteric modulators revealed by mutagenesis and a revised structural model. Mol Pharmacol 93:128–140
Ni D, Lu S, Zhang J (2018) Methods applied for the allosteric site revelation. Encycl Anal Chem:1–13. https://doi.org/10.1002/9780470027318.a9614
Niu W, Wang J, Qian J, Wang M, Wu P, Chen F, Yan S (2018) Allosteric control of human cystathionine β-synthase activity by a redox active disulfide bond. J Biol Chem 293:2523–2533
Nussinov R (2016) Introduction to protein ensembles and allostery. Chem Rev 116:6263–6266
Nussinov R, Tsai C-J (2012) The different ways through which specificity works in orthosteric and allosteric drugs. Curr Pharm Des 18:1311–1316
Nussinov R, Tsai C-J (2013) Allostery in disease and in drug discovery. Cell 153:293–305
Nussinov R, Tsai C-J (2014) Unraveling structural mechanisms of allosteric drug action. Trends Pharmacol Sci 35:256–264
Nussinov R, Tsai C-J (2015) The design of covalent allosteric drugs. Annu Rev Pharmacol Toxicol 55:249–267
Nussinov R, Tsai C-J, Csermely P (2011) Allo-network drugs: harnessing allostery in cellular networks. Trends Pharmacol Sci 32:686–693
Nussinov R, Tsai C-J, Xin F, Radivojac P (2012) Allosteric post-translational modification codes. Trends Biochem Sci 37:447–455
Nussinov R, Ma B, Tsai C-J, Csermely P (2013) Allosteric conformational barcodes direct signaling in the cell. Structure 21:1509–1521
Nussinov R, Tsai C-J, Liu J (2014) Principles of allosteric interactions in cell signaling. J Am Chem Soc 136:17692–17701
Omer A, Prasad CVSS (2012) Designing allosteric modulators for active conformational state of m-glutamate G-protein coupled receptors. Bioinformation 8:170–174
Otero LH, Rojas-Altuve A, Llarrull LI, Carrasco-López C, Kumarasiri M, Lastochkin E, Fishovitz J, Dawley M, Hesek D, Lee M, Johnson JW, Fisher JF, Chang M, Mobashery S, Hermoso JA (2013) How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. Proc Natl Acad Sci U S A 110:16808–16813
Pan Y, Tsai C-J, Ma B, Nussinov R (2010) Mechanisms of transcription factor selectivity. Trends Genet 26:75–83
Panjkovich A, Daura X (2012) Exploiting protein flexibility to predict the location of allosteric sites. BMC Bioinformatics 13:273
Patricelli MP, Janes MR, Li L-S, Hansen R, Peters U, Kessler LV, Chen Y, Kucharski JM, Feng J, Ely T, Chen JH, Firdaus SJ, Babbar A, Ren P, Liu Y (2016) Selective inhibition of oncogenic KRAS output with small molecules targeting the inactive state. Cancer Discov 6:316–329
Pfaff SJ, Fletterick RJ (2010) Hormone and co-regulator binding to the glucocorticoid receptor are allosterically coupled. J Biol Chem 285:15256–15267
Pinney MM, Natarajan A, Yabukarski F, Sanchez DM, Liu F, Liang R, Doukov T, Schwans JP, Martinez TJ, Herschlag D (2018) Structural coupling throughout the active site hydrogen bond networks of ketosteroid isomerase and photoactive yellow protein. J Am Chem Soc 140:9827–9843
Plattner N, Doerr S, De Fabritiis G, Noé F (2017) Complete protein–protein association kinetics in atomic detail revealed by molecular dynamics simulations and Markov modelling. Nat Chem 9:1005–1011
Popovych N, Sun S, Ebright RH, Kalodimos CG (2006) Dynamically driven protein allostery. Nat Struct Mol Biol 13:831–838
Prakash P, Sayyed-Ahmad A, Gorfe AA (2015) pMD-Membrane: a method for ligand binding site Identification in membrane-bound proteins. PLoS Comput Biol 11:e1004469
Rabiller M, Getlik M, Klüter S, Richters A, Tückmantel S, Simard JR, Rauh D (2010) Proteus in the world of proteins: conformational changes in protein kinases. Arch der Pharm An Int J Pharm Med Chem 343:193–206
Ramírez-Aportela E, López-Blanco JR, Andreu JM, Chacón P (2014) Understanding nucleotide-regulated FtsZ filament dynamics and the monomer assembly switch with large-scale atomistic simulations. Biophys J 107:2164–2176
Rask-Andersen M, Zhang J, Fabbro D, Schiöth HB (2014) Advances in kinase targeting: current clinical use and clinical trials. Trends Pharmacol Sci 35:604–620
Rescifina A, Scala A, Sciortino MT, Colao I, Siracusano G, Mazzaglia A, Chiacchio U, Grassi G (2015) Decorated 6, 6′, 7, 7′-tetrahydro-1 H, 1′ H-2, 3′-biindole scaffold as promising candidate for recognition of the CDK2 allosteric site. Medchemcomm 6:311–318
Reynolds KA, McLaughlin RN, Ranganathan R (2011) Hot spots for allosteric regulation on protein surfaces. Cell 147:1564–1575
Rose PW, Bi C, Bluhm WF, Christie CH, Dimitropoulos D, Dutta S, Green RK, Goodsell DS, Prlić A, Quesada M (2012) The RCSB Protein Data Bank: new resources for research and education. Nucleic Acids Res 41:D475–D482
Rose PW, Prlić A, Altunkaya A, Bi C, Bradley AR, Christie CH, Di Costanzo L, Duarte JM, Dutta S, Feng Z, Green RK, Goodsell DS, Hudson B, Kalro T, Lowe R, Ezra Peisach SKB (2017) The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic Acids Res 45:D271–D281
Roskoski R (2004) Src protein–tyrosine kinase structure and regulation. Biochem Biophys Res Commun 324:1155–1164
Roth BL, Irwin JJ, Shoichet BK (2017) Discovery of new GPCR ligands to illuminate new biology. Nat Chem Biol 13:1143–1151
Ruff EF, Muretta JM, Thompson AR, Lake EW, Cyphers S, Albanese SK, Hanson SM, Behr JM, Thomas DD, Chodera JD (2018) A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation. Elife 7:e32766
Saavedra HG, Wrabl JO, Anderson JA, Li J, Hilser VJ (2018) Dynamic allostery can drive cold adaptation in enzymes. Nature 558:324–328
Sadowsky JD, Burlingame MA, Wolan DW, McClendon CL, Jacobson MP, Wells JA (2011) Turning a protein kinase on or off from a single allosteric site via disulfide trapping. Proc Natl Acad Sci U S A 108:6056–6061
Scheer JM, Romanowski MJ, Wells JA (2006) A common allosteric site and mechanism in caspases. Proc Natl Acad Sci U S A 103:7595–7600
Schelshorn D, Joly F, Mutel S, Hampe C, Breton B, Mutel V, Lütjens R (2012) Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation. Mol Pharmacol 81:309–318
Schiffmann A, Gimpl G (2018) Sodium functions as a negative allosteric modulator of the oxytocin receptor. Biochim Biophys Acta – Biomembr 1860:1301–1308
Schnell JR, Dyson HJ, Wright PE (2004) Structure, dynamics, and catalytic function of dihydrofolate reductase. Annu Rev Biophys Biomol Struct 33:119–140
Sebastian B, Kakizuka A, Hunter T (1993) Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci U S A 90:3521–3524
Shen Q, Wang G, Li S, Liu X, Lu S, Chen Z, Song K, Yan J, Geng L, Huang Z, Huang W, Chen G, Zhang J (2016) ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks. Nucleic Acids Res 44:D527–D535
Shi Y (2014) A glimpse of structural biology through X-ray crystallography. Cell 159:995–1014
Shukla D, Meng Y, Roux B, Pande VS (2014) Activation pathway of Src kinase reveals intermediate states as targets for drug design. Nat Commun 5:3397
Sinha N, Nussinov R (2001) Point mutations and sequence variability in proteins: redistributions of preexisting populations. Proc Natl Acad Sci U S A 98:3139–3144
Skora L, Mestan J, Fabbro D, Jahnke W, Grzesiek S (2013) NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitors. Proc Natl Acad Sci U S A 110:E4437–E4445
Smith RD, Lu J, Carlson HA (2017) Are there physicochemical differences between allosteric and competitive ligands? PLoS Comput Biol 13:e1005813
Song GJ, Jung M, Kim J-H, Park H, Rahman MH, Zhang S, Zhang Z-Y, Park DH, Kook H, Lee I-K (2016) A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation. J Neuroinflammation 13:86
Song K, Liu X, Huang W, Lu S, Shen Q, Zhang L, Zhang J (2017) Improved method for the identification and validation of allosteric sites. J Chem Inf Model 57:2358–2363
Stetz G, Verkhivker GM (2017) Computational analysis of residue interaction networks and coevolutionary relationships in the Hsp70 chaperones: a community-hopping model of allosteric regulation and communication. PLoS Comput Biol 13:e1005299
Stothard P (2000) The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences. Biotechniques 28:1102–1104
Strickland D, Moffat K, Sosnick TR (2008) Light-activated DNA binding in a designed allosteric protein. Proc Natl Acad Sci U S A 105:10709–10714
Szilágyi A, Nussinov R, Csermely P (2013) Allo-network drugs: extension of the allosteric drug concept to protein-protein interaction and signaling networks. Curr Top Med Chem 13:64–77
Tan CM, Therien AG, Lu J, Lee SH, Caron A, Gill CJ, Lebeau-Jacob C, Benton-Perdomo L, Monteiro JM, Pereira PM (2012) Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics. Sci Transl Med 4:126ra35
Taylor SS, Kornev AP (2011) Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci 36:65–77
Teşileanu T, Colwell LJ, Leibler S (2015) Protein sectors: Statistical coupling analysis versus conservation. PLoS Comput Biol 11:e1004091
Thal DM, Glukhova A, Sexton PM, Christopoulos A (2018) Structural insights into G-protein-coupled receptor allostery. Nature 559:45–53
Tompa P (2012) Intrinsically disordered proteins: a 10-year recap. Trends Biochem Sci 37:509–516
Tsai C-J, Nussinov R (2014) A Unified View of “How Allostery Works.”. PLOS Comput Biol 10:e1003394
Tzeng S-R, Kalodimos CG (2011) Protein dynamics and allostery: an NMR view. Curr Opin Struct Biol 21:62–67. https://doi.org/10.1016/j.sbi.2010.10.007
Urwyler S (2011) Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol Rev 63:59–126
Van Wart AT, Durrant J, Votapka L, Amaro RE (2014) Weighted implementation of suboptimal paths (WISP): an optimized algorithm and tool for dynamical network analysis. J Chem Theory Comput 10:511–517
van Westen GJP, Gaulton A, Overington JP (2014) Chemical, target, and bioactive properties of allosteric modulation. PLOS Comput Biol 10:e1003559
Verespy S III, Mehta AY, Afosah D, Al-Horani RA, Desai UR (2016) Allosteric partial inhibition of monomeric proteases. Sulfated coumarins induce regulation, not just inhibition, of thrombin. Sci Rep 6:24043
Verkhivker GM (2016) Molecular dynamics simulations and modelling of the residue interaction networks in the BRAF kinase complexes with small molecule inhibitors: probing the allosteric effects of ligand-induced kinase dimerization and paradoxical activation. Mol Biosyst 12:3146–3165
Verkhivker GM (2017) Leveraging structural diversity and allosteric regulatory mechanisms of protein kinases in the discovery of small molecule inhibitors. Curr Med Chem 24:4838–4872
Viganò E, Diamond CE, Spreafico R, Balachander A, Sobota RM, Mortellaro A (2015) Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat Commun 6:8761
Wagner JR, Lee CT, Durrant JD, Malmstrom RD, Feher VA, Amaro RE (2016) Emerging computational methods for the rational discovery of allosteric drugs. Chem Rev 116:6370–6390
Wei H, Mo J, Tao L, Russell RJ, Tymiak AA, Chen G, Iacob RE, Engen JR (2014) Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications. Drug Discov Today 19:95–102
Wenthur CJ, Gentry PR, Mathews TP, Lindsley CW (2014) Drugs for allosteric sites on receptors. Annu Rev Pharmacol Toxicol 54:165–184
Whittaker SR, Barlow C, Martin MP, Mancusi C, Wagner S, Self A, Barrie E, Te Poele R, Sharp S, Brown N (2018) Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor. Mol Oncol 12:287–304
Wilhelm A, Lopez-Garcia LA, Busschots K, Fröhner W, Maurer F, Boettcher S, Zhang H, Schulze JO, Biondi RM, Engel M (2012) 2-(3-Oxo-1,3-diphenylpropyl)malonic acids as potent allosteric ligands of the PIF pocket of phosphoinositide-dependent Kinase-1: development and prodrug concept. J Med Chem 55:9817–9830. https://doi.org/10.1021/jm3010477
Wootten D, Christopoulos A, Sexton PM (2013) Emerging paradigms in GPCR allostery: implications for drug discovery. Nat Rev Drug Discov 12:630–644
Wright PE, Dyson HJ (2014) Intrinsically disordered proteins in cellular signalling and regulation. Nat Rev Mol Cell Biol 16:18–29
Wu P, Clausen MH, Nielsen TE (2015) Allosteric small-molecule kinase inhibitors. Pharmacol Ther 156:59–68
Xu Y, Smith R, Vivoli M, Ema M, Goos N, Gehrke S, Harmer NJ, Wagner GK (2017) Covalent inhibitors of LgtC: a blueprint for the discovery of non-substrate-like inhibitors for bacterial glycosyltransferases. Bioorg Med Chem 25:3182–3194
Xu Y, Wang S, Hu Q, Gao S, Ma X, Zhang W, Shen Y, Chen F, Lai L, Pei J (2018) CavityPlus: a web server for protein cavity detection with pharmacophore modelling, allosteric site identification and covalent ligand binding ability prediction. Nucleic Acids Res 46:W374–W379
Yang J-S, Seo SW, Jang S, Jung GY, Kim S (2012) Rational engineering of enzyme allosteric regulation through sequence evolution analysis. PLoS Comput Biol 8:e1002612
Yau M-K, Liu L, Fairlie DP (2013) Toward drugs for protease-activated receptor 2 (PAR2). J Med Chem 56:7477–7497
Youssef EA, Berry-Kravis E, Czech C, Hagerman RJ, Hessl D, Wong CY, Rabbia M, Deptula D, John A, Kinch R (2018) Effect of the mGluR5-NAM basimglurant on behavior in adolescents and adults with Fragile X syndrome in a randomized, double-blind, placebo-controlled trial: fragXis phase 2 results. Neuropsychopharmacology 43:503–512
Zhu R, Song Y, Liu H, Yang Y, Wang S, Yi C, Chen PR (2017) Allosteric histidine switch for regulation of intracellular zinc(II) fluctuation. Proc Natl Acad Sci U S A 114:13661–13666
Zuehlke AD, Moses MA, Neckers L (2018) Heat shock protein 90: its inhibition and function. Phil Trans R Soc B 373:20160527
Acknowledgments
This work was supported by the National Natural Science Foundation of China (21778037; Shanghai Health and Family Planning Commission (20154Y0058), the Fundamental Research Funds for the Central Universities, and the Chun-Tsung project (No.2018-02-04).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
He, X., Ni, D., Lu, S., Zhang, J. (2019). Characteristics of Allosteric Proteins, Sites, and Modulators. In: Zhang, J., Nussinov, R. (eds) Protein Allostery in Drug Discovery. Advances in Experimental Medicine and Biology, vol 1163. Springer, Singapore. https://doi.org/10.1007/978-981-13-8719-7_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-8719-7_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8718-0
Online ISBN: 978-981-13-8719-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)